Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Mast Cells in Neurodegenerative Disease.

Jones MK, Nair A, Gupta M.

Front Cell Neurosci. 2019 Apr 30;13:171. doi: 10.3389/fncel.2019.00171. eCollection 2019.

2.

Mast cells in neuroinflammation and brain disorders.

Hendriksen E, van Bergeijk D, Oosting RS, Redegeld FA.

Neurosci Biobehav Rev. 2017 Aug;79:119-133. doi: 10.1016/j.neubiorev.2017.05.001. Epub 2017 May 10. Review. Erratum in: Neurosci Biobehav Rev. 2017 Dec;83:774.

PMID:
28499503
3.

Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases.

Girolamo F, Coppola C, Ribatti D.

Brain Behav Immun. 2017 Oct;65:68-89. doi: 10.1016/j.bbi.2017.06.017. Epub 2017 Jul 1. Review.

PMID:
28676349
4.

Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis.

Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Raikwar SP, Iyer SS, Bhagavan SM, Beladakere-Ramaswamy S, Zaheer A.

Front Neurosci. 2017 Dec 12;11:703. doi: 10.3389/fnins.2017.00703. eCollection 2017. Review.

5.

Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S, Zaheer A.

Front Cell Neurosci. 2017 Jul 24;11:216. doi: 10.3389/fncel.2017.00216. eCollection 2017. Review.

6.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14. Review.

PMID:
27046268
7.

Microglia-mediated neuroinflammation in neurodegenerative diseases.

Subhramanyam CS, Wang C, Hu Q, Dheen ST.

Semin Cell Dev Biol. 2019 May 11. pii: S1084-9521(18)30089-2. doi: 10.1016/j.semcdb.2019.05.004. [Epub ahead of print] Review.

PMID:
31077796
8.

Neuroinflamm-aging and neurodegenerative diseases: an overview.

Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A.

CNS Neurol Disord Drug Targets. 2011 Aug;10(5):621-34. Review.

PMID:
21631404
9.

Innate Immunity and Neurodegeneration.

Labzin LI, Heneka MT, Latz E.

Annu Rev Med. 2018 Jan 29;69:437-449. doi: 10.1146/annurev-med-050715-104343. Epub 2017 Nov 6.

PMID:
29106805
10.

Emerging roles of protein kinases in microglia-mediated neuroinflammation.

Lee SH, Suk K.

Biochem Pharmacol. 2017 Dec 15;146:1-9. doi: 10.1016/j.bcp.2017.06.137. Epub 2017 Jul 4. Review.

PMID:
28684305
11.

T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.

González H, Pacheco R.

J Neuroinflammation. 2014 Dec 2;11:201. doi: 10.1186/s12974-014-0201-8. Review.

12.

Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.

Rivera S, García-González L, Khrestchatisky M, Baranger K.

Cell Mol Life Sci. 2019 Jun 13. doi: 10.1007/s00018-019-03178-2. [Epub ahead of print] Review.

PMID:
31197405
13.

Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer's Disease.

Kempuraj D, Mentor S, Thangavel R, Ahmed ME, Selvakumar GP, Raikwar SP, Dubova I, Zaheer S, Iyer SS, Zaheer A.

Front Cell Neurosci. 2019 Feb 19;13:54. doi: 10.3389/fncel.2019.00054. eCollection 2019.

14.

Role of Microglia TLRs in Neurodegeneration.

Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP.

Front Cell Neurosci. 2018 Oct 2;12:329. doi: 10.3389/fncel.2018.00329. eCollection 2018.

15.

The brain as a target for inflammatory processes and neuroprotective strategies.

Skaper SD.

Ann N Y Acad Sci. 2007 Dec;1122:23-34. Review.

PMID:
18077562
16.

Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration.

Batista CRA, Gomes GF, Candelario-Jalil E, Fiebich BL, de Oliveira ACP.

Int J Mol Sci. 2019 May 9;20(9). pii: E2293. doi: 10.3390/ijms20092293. Review.

17.

Differential contribution of microglia and monocytes in neurodegenerative diseases.

Baufeld C, O'Loughlin E, Calcagno N, Madore C, Butovsky O.

J Neural Transm (Vienna). 2018 May;125(5):809-826. doi: 10.1007/s00702-017-1795-7. Epub 2017 Oct 23. Review.

PMID:
29063348
18.

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.

Cassano T, Calcagnini S, Pace L, De Marco F, Romano A, Gaetani S.

Front Neurosci. 2017 Feb 2;11:30. doi: 10.3389/fnins.2017.00030. eCollection 2017. Review.

19.

Neuroinflammation Induces Neurodegeneration.

Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, Zaheer S, Iyer SS, Zaheer A.

J Neurol Neurosurg Spine. 2016;1(1). pii: 1003. Epub 2016 Nov 18.

20.

Inflammation in CNS neurodegenerative diseases.

Stephenson J, Nutma E, van der Valk P, Amor S.

Immunology. 2018 Jun;154(2):204-219. doi: 10.1111/imm.12922. Epub 2018 Apr 17. Review.

Supplemental Content

Support Center